Louder than a gasp, RFK Jr. slammed mammography as a possible overreach. He claimed that routine breast‑screening could blind patients to real threats better than the public has known.
In early March, the former Democratic aide turned activist staged a press briefing that many expected would be about vaccines again. Instead, he handed a flyer that read, “Preventive care that points at pain.” The image slapped the word “mammogram” in front of headlines and the headlines— that’s the buzz. The crowd shared the clip like a viral meme, and doctors in the room shouted, “This is nonsense!”
It’s no secret that RFK Jr. has united himself with the anti‑vaccine movement for years. He’s made headlines for housingspiracy theories that the flu shot is a mind‑control device, and he has sued pharmaceutical giants. This new attack on mammograms feels like a sideways extension of that narrative, because he places the argument on the same simple bullet: “What goes into you might hurt you.”
In his own words, and according to reporters, he warned that medical boards that succeeded in stopping vaccine misinformation seemed also to be turning a blind eye to “over‑screening.” He said the medical field might be out of step because it “misses the cost of unnecessary radiation.” Though doctors said they’d never be surprised by the claim, only that it was a step toward a larger hazard. Health experts say that while any scan’s radiation is minimal, the fact that doctors don’t fully quantify that risk is far from unusual in modern medicine.
When he spoke, the room cracked. A junior physician in the crowd called his comments “unprofessional.” A senior radiologist pressed his watch and said, “We follow guidelines from the American Cancer Society and the U.S. Preventive Services Task Force.” He added, “The guidelines aren’t made on speculation; they’re evidence.” Even the panel of vaccine critics in the audience nodded, but when one said, “She’s right. Knowing the effects of medicine is crucial,” it broke the silence and kept the conversation alive. A lingering question:
